Back to Search

DOOHYUN LIM, PHARMD

PHARMD

Pharmacist

NPI: 1801110374Individual

Specialties, Licenses & Credentials

PharmacistPrimary

Pharmacist

Code: 183500000X

20053382(NY)RI03021900(NJ)

Research & Publications (20)

Suggestion of potential stent design parameters to reduce restenosis risk driven by foreshortening or dogboning due to non-uniform balloon-stent expansion.
PMID 18437572·Ann Biomed Eng·2008
7-preclinical
Development and clinical testing of an ultrasonic diagnostic system for functional gastrointestinal disorders.
PMID 18255221·Ultrasound Med Biol·2008
7-preclinical
Expression of MET in alveolar soft part sarcoma.
PMID 19472090·Med Oncol·2010
4-observational
Temporal induction of secretory leukocyte protease inhibitor (SLPI) in odontoblasts by lipopolysaccharide and wound infection.
PMID 19567322·J Endod·2009
7-preclinical
Microfabricating high-aspect-ratio structures in polyurethane-methacrylate (PUMA) disposable microfluidic devices.
PMID 19532971·Lab Chip·2009
8-other
High-dose chemotherapy and autologous stem cell rescue in patients with high-risk stage 3 neuroblastoma: 10-year experience at a single center.
PMID 19654949·J Korean Med Sci·2009
5-case
beta-Sheet-breaking peptides inhibit the fibrillation of human alpha-synuclein.
PMID 19622344·Biochem Biophys Res Commun·2009
8-other
Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1.
PMID 19597481·Nat Struct Mol Biol·2009
8-other
Rapid dead-end ultrafiltration concentration and biosensor detection of enterococci from beach waters of Southern California.
PMID 19590135·J Water Health·2009
8-other
Intraoperative MRI in functional neurosurgery. Preface.
PMID 19555874·Neurosurg Clin N Am·2009
8-other
Novel treatment strategies for malignant gliomas using neural stem cells.
PMID 19560736·Neurotherapeutics·2009
6-review
Liposarcoma: exploration of clinical prognostic factors for risk based stratification of therapy.
PMID 19558664·BMC Cancer·2009
8-other
A retrospective study to compare two methotrexate-based regimens for primary central nervous system lymphoma.
PMID 19557631·Leuk Lymphoma·2009
8-other
Future directions: use of interventional MRI for cell-based therapy of Parkinson disease.
PMID 19555884·Neurosurg Clin N Am·2009
6-review
Asiatic acid derivatives protect primary cultures of rat hepatocytes against carbon tetrachloride-induced injury via the cellular antioxidant system.
PMID 19634318·Nat Prod Commun·2009
7-preclinical
Cancer-upregulated gene 2 (CUG2), a new component of centromere complex, is required for kinetochore function.
PMID 19533040·Mol Cells·2009
7-preclinical
Clinical outcome of concomitant chemoradiotherapy followed by adjuvant temozolomide therapy for glioblastaomas: single-center experience.
PMID 19640635·Clin Neurol Neurosurg·2009
3-trial
Stochastic actin polymerization and steady retrograde flow determine growth cone advancement.
PMID 19527673·Biophys J·2009
7-preclinical
Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.
PMID 19664131·APMIS·2009
8-other
Recurrent giant fibrovascular polyp of the esophagus.
PMID 19653354·World J Gastroenterol·2009
5-case

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
2375 HUDSON TER APT 1E
FORT LEE, NJ 07024

Location

Practice Location

2375 HUDSON TER APT 1E, FORT LEE, NJ
(201) 693-3956

Quick Facts

NPI
1801110374
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
2
Locations
1
Publications
20

Are you this provider?

Claim Your Profile